4 Result(s) found
Current Studies
20230222: A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing Olpasiran Use to Prevent First Major Cardiovascular Events in High Risk Subjects with Elevated Lipoprotein(a) (AMG 890)
Primary To evaluate the effect of olpasiran, compared to placebo, on the risk for coronary heart disease death (CHD death), myocardial infarction or urgent coronary revascularization in high-risk participants with elevated Lipoprotein(a) Key Secondary To evaluate the effect of olpasiran, compared...
View DetailsCurrent Studies
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE - RESTORE
Primary Objectives: To determine the acute and long-term outcomes of redo TAVR for the treatment of BVF affecting TAVs To determine the factors which are associated with the acute and long-term outcomes of redo TAVR
View DetailsCurrent Studies
A Randomized Controlled Study of the Prevail Drug-Coated Balloon in Subjects With In-stent Restenosis and a Single Arm Prospectively Enrolled Study of the Prevail Drug-Coated Balloon for de Novo Lesions in Small Vessel Disease (Prevail Global).
Experimental: ISR Corhort Prevail DCB -To evaluate the clinical safety and efficacy of the Prevail DCB in the treatment of ISR with coronary lesions previously treated with drug-eluting or bare metal stents in native coronary arteries. Experimental: DNSV Cohort (RVD 2.0 - 2.75mm) -To evaluate the...
View DetailsCurrent Studies
(A Randomized, Comparative Effectiveness Study of Staged Complete Revascularization with Percutaneous Coronary Intervention to Treat Coronary Artery Disease vs Medical Management Alone in Patients with Symptomatic Aortic Valve Stenosis undergoing Elective
Primary Objective: To determine whether, on a background of guideline-directed medical therapy, a strategy of complete revascularization involving staged PCI using drug eluting stents to treat all suitable coronary artery lesions is superior to a strategy of medical therapy alone in reducing the...
View Details